• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情时期的合理疫苗设计。

Rational Vaccine Design in the Time of COVID-19.

机构信息

The Scripps Research Institute, La Jolla, CA 92037, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.

Adimab, Lebanon, NH 03766, USA.

出版信息

Cell Host Microbe. 2020 May 13;27(5):695-698. doi: 10.1016/j.chom.2020.04.022.

DOI:10.1016/j.chom.2020.04.022
PMID:32407707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7219357/
Abstract

As scientists consider SARS-CoV-2 vaccine design, we discuss problems that may be encountered and how to tackle them by what we term "rational vaccine design." We further discuss approaches to pan-coronavirus vaccines. We draw on experiences from recent research on several viruses including HIV and influenza, as well as coronaviruses.

摘要

当科学家们考虑 SARS-CoV-2 疫苗设计时,我们讨论了可能遇到的问题,并通过我们所谓的“理性疫苗设计”来讨论如何解决这些问题。我们进一步讨论了泛冠状病毒疫苗的方法。我们借鉴了最近对包括 HIV 和流感在内的几种病毒以及冠状病毒的研究经验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80a/7219357/64bdb2974433/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80a/7219357/64bdb2974433/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80a/7219357/64bdb2974433/gr1_lrg.jpg

相似文献

1
Rational Vaccine Design in the Time of COVID-19.新冠疫情时期的合理疫苗设计。
Cell Host Microbe. 2020 May 13;27(5):695-698. doi: 10.1016/j.chom.2020.04.022.
2
COVID-19 shot protects monkeys.新冠疫苗对猴子有保护作用。
Science. 2020 May 1;368(6490):456-457. doi: 10.1126/science.368.6490.456.
3
Rapid COVID-19 vaccine development.新冠疫苗的快速研发。
Science. 2020 May 29;368(6494):945-946. doi: 10.1126/science.abb8923. Epub 2020 May 8.
4
'I've never worked harder': the race to develop a COVID-19 vaccine.“我从未如此努力工作过”:新冠疫苗的研发竞赛
Nature. 2020 Nov;587(7833):322. doi: 10.1038/d41586-020-03139-x.
5
What the immune response to the coronavirus says about the prospects for a vaccine.对冠状病毒的免疫反应揭示了疫苗的前景。
Nature. 2020 Sep;585(7823):20-21. doi: 10.1038/d41586-020-02400-7.
6
Progress and Concept for COVID-19 Vaccine Development.新型冠状病毒肺炎疫苗研发进展与理念
Biotechnol J. 2020 Jun;15(6):e2000147. doi: 10.1002/biot.202000147. Epub 2020 May 7.
7
A vaccine is not too far for COVID-19.针对新冠病毒的疫苗已为时不远。
J Infect Dev Ctries. 2020 May 31;14(5):450-453. doi: 10.3855/jidc.12744.
8
Coronavirus vaccines get a biotech boost.冠状病毒疫苗获得生物技术助力。
Nature. 2020 Jul;583(7817):647-649. doi: 10.1038/d41586-020-02154-2.
9
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告:评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
10
Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using Evolution and Reverse Genetics.在大流行爆发前利用进化和反向遗传学开发针对2019冠状病毒病的疫苗
Front Immunol. 2020 Aug 14;11:2051. doi: 10.3389/fimmu.2020.02051. eCollection 2020.

引用本文的文献

1
Beyond COVID-19: the promise of next-generation coronavirus vaccines.超越新冠疫情:下一代冠状病毒疫苗的前景
Npj Viruses. 2024 Aug 22;2(1):39. doi: 10.1038/s44298-024-00043-3.
2
Immunological drivers of zoonotic virus emergence, evolution, and endemicity.人畜共患病毒出现、进化和地方性流行的免疫学驱动因素。
Immunity. 2025 Apr 8;58(4):784-796. doi: 10.1016/j.immuni.2025.03.014. Epub 2025 Mar 31.
3
Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes.深度库挖掘揭示了针对多个刺突表位的超广谱冠状病毒中和抗体。

本文引用的文献

1
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.2019 年新型冠状病毒刺突蛋白在预融合构象的冷冻电镜结构
Science. 2020 Mar 13;367(6483):1260-1263. doi: 10.1126/science.abb2507. Epub 2020 Feb 19.
2
Engineered immunogen binding to alum adjuvant enhances humoral immunity.工程化免疫原与铝佐剂结合可增强体液免疫。
Nat Med. 2020 Mar;26(3):430-440. doi: 10.1038/s41591-020-0753-3. Epub 2020 Feb 17.
3
A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.
Cell Rep. 2024 Jun 25;43(6):114307. doi: 10.1016/j.celrep.2024.114307. Epub 2024 Jun 5.
4
The Application of Mesenchymal Stem Cells in Future Vaccine Synthesis.间充质干细胞在未来疫苗合成中的应用。
Vaccines (Basel). 2023 Oct 24;11(11):1631. doi: 10.3390/vaccines11111631.
5
Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice.疫苗介导的对 Merbecovirus 和 Sarbecovirus 挑战的保护作用在小鼠中。
Cell Rep. 2023 Oct 31;42(10):113248. doi: 10.1016/j.celrep.2023.113248. Epub 2023 Oct 18.
6
Preclinical evaluation of general toxicity and safety pharmacology of a receptor-binding domain-based COVID-19 subunit vaccine in various animal models.在各种动物模型中评估基于受体结合域的 COVID-19 亚单位疫苗的一般毒性和安全性药理学的临床前评价。
Arch Toxicol. 2023 Sep;97(9):2429-2440. doi: 10.1007/s00204-023-03549-6. Epub 2023 Jul 25.
7
Antiviral neutralizing antibodies: from in vitro to in vivo activity.抗病毒中和抗体:从体外到体内活性。
Nat Rev Immunol. 2023 Nov;23(11):720-734. doi: 10.1038/s41577-023-00858-w. Epub 2023 Apr 17.
8
Exploring the Potential of Broadly Neutralizing Antibodies for Treating SARS-CoV-2 Variants of Global Concern in 2023: A Comprehensive Clinical Review.探索2023年用于治疗全球关注的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的广泛中和抗体的潜力:一项全面的临床综述
Cureus. 2023 Mar 28;15(3):e36809. doi: 10.7759/cureus.36809. eCollection 2023 Mar.
9
Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine.ISA 51 佐剂的 SARS-CoV-2 刺突 RBD-Fc 疫苗在肥胖小鼠中引发强烈的中和抗体反应。
Appl Microbiol Biotechnol. 2023 May;107(9):2983-2995. doi: 10.1007/s00253-023-12490-8. Epub 2023 Mar 29.
10
Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses.由 COVID-19 康复期记忆 B 细胞构建的单克隆抗体对 MERS-CoV 刺突 S2 亚单位和其他人类冠状病毒表现出很强的结合活性。
Front Immunol. 2022 Dec 22;13:1056272. doi: 10.3389/fimmu.2022.1056272. eCollection 2022.
一种基于 Zika 病毒 E-二聚体的保护性亚单位疫苗,经工程改造后可消除抗体依赖性增强登革热感染的作用。
Nat Immunol. 2019 Oct;20(10):1291-1298. doi: 10.1038/s41590-019-0477-z. Epub 2019 Sep 2.
4
Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance.延迟接种疫苗可通过调节免疫优势增强 HIV 中和抗体和生发中心反应。
Cell. 2019 May 16;177(5):1153-1171.e28. doi: 10.1016/j.cell.2019.04.012. Epub 2019 May 9.
5
Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.病毒感染的被动免疫疗法:“超级抗体”加入战局。
Nat Rev Immunol. 2018 May;18(5):297-308. doi: 10.1038/nri.2017.148. Epub 2018 Jan 30.
6
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.一种合理设计的预融合 MERS-CoV 刺突抗原的免疫原性和结构。
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7348-E7357. doi: 10.1073/pnas.1707304114. Epub 2017 Aug 14.
7
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.2015年韩国,中东呼吸综合征冠状病毒症状出现1年后的抗体反应
Emerg Infect Dis. 2017 Jul;23(7):1079-1084. doi: 10.3201/eid2307.170310. Epub 2017 Jul 15.
8
What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise.什么是最有效的免疫原设计疫苗策略?反向疫苗学 2.0 展现出巨大的潜力。
Cold Spring Harb Perspect Biol. 2017 Nov 1;9(11):a030262. doi: 10.1101/cshperspect.a030262.
9
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination.生发中心起始阶段持续的抗原可用性可增强对疫苗接种的抗体反应。
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):E6639-E6648. doi: 10.1073/pnas.1606050113. Epub 2016 Oct 4.
10
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer.冠状病毒刺突糖蛋白三聚体的冷冻电子显微镜结构
Nature. 2016 Mar 3;531(7592):114-117. doi: 10.1038/nature16988. Epub 2016 Feb 8.